Targeting tumor-specific inflammatory process may prevent drug resistance in colon cancer Post author:admin Post published:May 21, 2026 Post category:uncategorized Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse. You Might Also Like Can creatine and resistance training trim your body fat percentage? October 16, 2023 New fragmentome technology can detect early liver fibrosis and cirrhosis March 4, 2026 AI breakthrough offers a new way to predict and visualize disease processes September 16, 2025